monumental-1: talquetamab for multiple myeloma
Published 2 years ago • 988 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
10:11
monumental-1: talquetamab in r/r multiple myeloma
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma
-
2:47
monumental-1: updated data on talquetamab in r/r myeloma
-
2:58
monumental-2: talquetamab plus pomalidomide in r/r multiple myeloma
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
9:25
mgus diagnosis: a step-by-step approach
-
49:38
off-the-shelf immune drug for aggressive multiple myeloma: teclistamab
-
1:55
monumental-1: incidence of severe infections & parameters of humoral immunity with talquetamab
-
5:54
redirectt-1 results: teclistamab talquetamab in r/r multiple myeloma
-
2:34
the effect of dose reduction of talquetamab in patients with r/r mm: results from monumental-1
-
0:46
2-year follow-up of majestec-1: teclistamab in r/r multiple myeloma
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
0:59
defining the origins of multiple myeloma
-
4:15
bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab
-
1:04
majestec-1: teclistamab for myeloma
-
2:25
first-in-human study of talquetamab: a gprc5d-cd3 bispecific antibody for r/r mm
-
1:18
updates from the monumental-1 trial
-
8:43
results from monumental-1: first-in-human study of talquetamab in pts with rr multiple myeloma
-
2:13
founding precision therapy for 1q-amplified multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies